Form 8-K - Current report:
SEC Accession No. 0001104659-23-108704
Filing Date
2023-10-12
Accepted
2023-10-12 08:00:28
Documents
12
Period of Report
2023-10-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2328076d2_8k.htm   iXBRL 8-K 27091
  Complete submission text file 0001104659-23-108704.txt   201085

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atxs-20231012.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20231012_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20231012_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2328076d2_8k_htm.xml XML 3325
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 231321732
SIC: 2834 Pharmaceutical Preparations